Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels (Q74471880)
Jump to navigation
Jump to search
scientific article published on 01 April 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels |
scientific article published on 01 April 1998 |
Statements
Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels (English)
H E Miettinen
H Gylling
J Tenhunen
J Virtamo
M Jauhiainen
J K Huttunen
I Kantola
T A Miettinen